117th Congress · HOUSE BILLBILL

H.R. 1384Mainstreaming Addiction Treatment Act of 2021

To amend section 303(g) of the Controlled Substances Act (21 U.S.C. 823(g)) to eliminate the separate registration requirement for dispensing narcotic drugs in schedule III, IV, or V (such as buprenorphine) for maintenance or detoxification treatment, and for other purposes.

Crime and law enforcement
Introduced Feb 25, 2021
Last action Apr 28, 2021
Pipeline · Bill → Law
Step 1
Introduced
Feb 25, 2021
Step 2
Referred
Apr 28, 2021
E&C · Judiciary · Ways & Means
Step 3
Committee
Step 4
House floor
Step 5
Senate
Step 6
Resolve Changes
Step 7
Signed
SummaryNo summary available

No CRS summary available for this bill.

Provisions · 4 sectionsIntroduced in House
Timeline · 7 actions
Apr 28, 2021
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Feb 26, 2021
Referred to the Subcommittee on Health.
Feb 25, 2021
Introduced in House
Feb 25, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Feb 25, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Feb 25, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Feb 25, 2021
Referred to the Subcommittee on Health.